Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)

NCT01381211 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
72
Enrollment
OTHER
Sponsor class

Stopped based on interim analysis results

Conditions

Interventions

Sponsor

University Hospital, Ghent